Polycythemia Vera
145 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate (NCT00038675) | M.D. Anderson Cancer Center | 2001-06-01 |
| Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147) | University of Illinois at Chicago | 2000-02-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |
| MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera (NCT05269771) | Novartis Pharmaceuticals |
Track Polycythemia Vera automatically
Every clearance here is in the API, with alerts when new ones post.